🔥🐔 BizChicken 🐔🔥
Companies Similar to Guardion Health Sciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
GE HealthCare Technologies Inc.
Healthcare products and digital solutions
GE Health Care Technologies Inc. develops, manufactures, and markets products, services, and digital solutions for patient diagnosis, treatment, and monitoring globally. It operates through segments including Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
About | Contact | About | Sustainability | News | About | Sustainability | Foundation | About | About | About | About | About | Jobs | Careers | Careers | Jobs | Jobs | Careers | Careers | DEI | Culture | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Culture | DEI | Careers | Sustainability | Careers | Careers | Careers | Careers | Vision/Values | Careers | Jobs | About | About | About | About | About
Symbol: GEHC
Recent Price: $78.60
Industry: Medical - Healthcare Information Services
CEO: Mr. Peter J. Arduini
Sector: Healthcare
Employees: 51000
Address: 500 West Monroe Street, Chicago, IL 60661
Phone: 617 443 3400
Last updated: 2024-12-31
Genelux Corporation
Olvi-Vec
Genelux Corporation is a clinical-stage biopharmaceutical company developing oncolytic viral immunotherapies for tough-to-treat cancers, with a lead product candidate, Olvi-Vec.
Management | Directors | About | Management | Directors | About | Contact | Contact | Contact | Careers | Careers | About | About | About | About | About
Symbol: GNLX
Recent Price: $2.40
Industry: Biotechnology
CEO: Mr. Thomas Zindrick J.D.
Sector: Healthcare
Employees: 24
Address: 2625 Townsgate Road, Westlake Village, CA 91361
Phone: 858 483 0024
Leadership
- Bob Smith, CTO
- THOMAS ZINDRICK, J.D., Chairman
- JAMES L. TYREE, MBA, Lead Independent Director
- MARY MIRABELLI, MBA, Chair, Nominating and Corporate Governance Committee
- JOHN THOMAS, M.A., MBA, Ph.D., Chair, Audit Committee
- JOHN SMITHER, Chair, Compensation Committee
- Alice Johnson, CEO
- Carol Davis, CFO
- David Wilson, Chairman
- Eva Brown, Director
Last updated: 2024-12-31
Regeneron Pharmaceuticals, Inc.
EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb
Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.
About | Leadership | About | History | About | About | Contact | Careers | Careers | Jobs | Jobs | Jobs | Careers | Culture | DEI | Careers | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Careers | Careers | Careers | Locations | Locations | Locations | Locations | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Site Map | Careers | About | About | About | About | Jobs | About | Leadership | Careers | Careers | About | Jobs | Jobs | Careers
Symbol: REGN
Recent Price: $702.59
Industry: Biotechnology
CEO: Dr. Leonard S. Schleifer M.D., Ph.D.
Sector: Healthcare
Employees: 14165
Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
Phone: 914 847 7000
Leadership
- Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
- George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
- Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
- Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
- Leonard Brooks, Senior Vice President, Treasurer
- John Calabro, Senior Vice President, Internal Audit
- Christina Chan, Senior Vice President, Corporate Affairs
- Larry Coury, PhD, Senior Vice President, Associate General Counsel
- Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
- Matthew Everett, Senior Vice President, Global Procurement
- Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
- Rick Hall, Senior Vice President, Human Resources
- Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
- Nouhad Husseini, Senior Vice President, Business Development
- Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
- Melissa Lozner, Senior Vice President, Chief Compliance Officer
- Marion McCourt, Executive Vice President, Commercial
- Bob McCowan, Senior Vice President, IT and Chief Information Officer
- Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
- Richard O’Neal, Senior Vice President, Market Access
- Sally A. Paull, Executive Vice President, Human Resources
- Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
- George Poth, Senior Vice President, Real Estate & Facilities Management
- Alessandra Ravetti, Senior Vice President, Associate General Counsel
- Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
- David Snow, Senior Vice President, Global Head, Dupixent Franchise
- Mark Volpe, Senior Vice President, Tax
- Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
- Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
- Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
- Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
- Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
- Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
- Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
- Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
- Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
- Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
- Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
- Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
- Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
- Christos Kyratsous, PhD, Senior Vice President, Research
- Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
- John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
- Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
- Lynn Macdonald, PhD, Senior Vice President, Research
- Lori Morton, PhD, Senior Vice President, Research
- Andrew Murphy, PhD, Executive Vice President, Research
- Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
- William Olson, PhD, Senior Vice President, Therapeutic Proteins
- Mohammed Shameem, PhD, Senior Vice President, Formulations Development
- L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
- Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
- Neil Stahl, PhD, Executive Vice President, Research and Development
- Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
- Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
- Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
- Frederick Austin, Senior Vice President, Quality Control, Raheen
- Christine Childrose, Senior Vice President, Human Resources and HR Operations
- David Crenshaw, Senior Vice President, Associate General Counsel
- Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
- Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
- Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
- Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
- Scott Oberman, Senior Vice President, Supply Chain Operations
- David Simon, Senior Vice President, IOPS Finance and Business Operations
- Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
- Benjamin Yocum, Senior Vice President, Manufacturing Operations
- James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
- Bonnie L. Bassler, PhD, Director
- Michael S. Brown, MD, Director
- N. Anthony Coles, MD, Chair of the Board
- Joseph L. Goldstein, MD, Director
- Kathryn Guarini, PhD, Director
- Christine A. Poon, Lead Independent Director
- Arthur F. Ryan, Director
- Huda Y. Zoghbi, MD, Director
- Samantha Dickon, Director, Development Program Management
- Gervasio Batista, Sr. Scientist, Neuroscience
- James K. Gibson, Senior Regional Director, Immunology/Pulmonary
- Beth Brause, Director, Field Reimbursement Management
- Eric Prendergast, Director, Pricing Strategy
- Ashley Neff, Manager, Digital Communications
- Shari Loock, Associate Director, Sourcing
- Jennifer Davidson Hamilton, VP and Head of Precision Medicine
- Yi Zhang, Director, Health Economics & Outcomes Research
- Wilson Caldwell III, Director, GCO Vendor & Relationship Management
- David Stein, Director, Medical Operations
- Regeneron, Corporate
- Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
- Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
- Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
- Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
- Jessie Brown, Manager, Integrative Translational Genetics
- Gisu Eom, Lead Cloud DevOps Engineer
- Carmen Kenworthy, Scientist, Velocigene
- Ralph Hazlewood, Sr. Manager, Research Program Management
- Brandy Bennett, Sr. Director, R&D Strategy & Operations
Last updated: 2024-12-31
Lucid Diagnostics Inc.
Eso Guard, Eso Check
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company focused on detecting esophageal precancer in patients with gastroesophageal reflux disease.
About | Leadership | Contact | Careers | Careers | About | About | About | About | About | Careers
Symbol: LUCD
Recent Price: $0.80
Industry: Medical - Devices
CEO: Dr. Lishan Aklog M.D.
Sector: Healthcare
Employees: 70
Address: One Grand Central Place, New York, NY 10165
Phone: 212 949 4319
Leadership
- Lishan Aklog, MD, Chairman, Chief Executive Officer
- Shaun O'Neil, MBA, President & Chief Operating Officer
- Dennis McGrath, Chief Financial Officer
- Michael Gordon, General Counsel & Corporate Secretary
- Suman M. Verma, MD, PhD, Chief Scientific Officer
- Victoria T. Lee, MD, Chief Medical Officer
- Brian deGuzman, MD, Chief Technology & Compliance Officer
- Deepika A. Lakhani, PhD, Chief Regulatory & Quality Officer
- Stanley N. Lapidus, Vice-Chairman
- James L. Cox, MD, Board Member
- Dennis Matheis, Board Member
- Jacque J. Sokolov, MD, Board Member
- Ron Sparks, Board Member
- Debbie White, Board Member
Last updated: 2024-12-31
Glaukos Corporation
i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR
Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.
Foundation | About | About | History | Foundation | Awards | About | Contact | Sustainability | Careers | Careers | About | About | About | About | About | About | Jobs
Symbol: GKOS
Recent Price: $149.51
Industry: Medical - Devices
CEO: Mr. Thomas William Burns
Sector: Healthcare
Employees: 907
Address: 229 Avenida Fabricante, San Clemente, CA 92672
Phone: 949 367 9600
Last updated: 2024-12-31
ChromaDex Corporation
NIAGEN, TRU NIAGEN, IMMULINA
Chroma Dex Corporation is a bioscience company focused on healthy aging, offering consumer products, ingredient technologies, and analytical reference standards. It specializes in NAD+ research and commercializes NAD+ precursor nicotinamide riboside (NIAGEN) and immune-supporting compounds.
Symbol: CDXC
Recent Price: $5.45
Industry: Biotechnology
CEO: Mr. Robert N. Fried
Sector: Healthcare
Employees: 106
Address: 10900 Wilshire Boulevard, Los Angeles, CA 90024
Phone: 310 388 6706
Last updated: 2024-12-31
Celcuity Inc.
CELsignia diagnostic platform
Celcuity Inc., a biotechnology company, develops targeted therapies for cancer patients in the US, including the CELsignia diagnostic platform and Gedatolisib drug candidate.
Symbol: CELC
Recent Price: $13.13
Industry: Biotechnology
CEO: Mr. Brian F. Sullivan
Sector: Healthcare
Employees: 55
Address: 16305–36th Avenue North, Minneapolis, MN 55446
Phone: 763 392 0767
Leadership
- Brian Sullivan, CEO and Co-founder
- Lance Laing, PhD, Chief Science Officer and Co-founder
- Vicky Hahne, CFO
- Igor Gorbatchevsky, MD, Chief Medical Officer
- Eldon Mayer, Chief Commercial Officer
- Brent Eilefson, General Counsel
- Bernhard Lampert, PhD, VP of Pharmaceutical Development
- Nadene Zack, VP Clinical Operations
- Sunni Miller, VP of Regulatory Affairs
- David Bridge, VP of Quality Assurance and Process Development
- William Strickland, PharmD, VP of Medical Affairs
- Fred Kerwood, VP of Program Management
- Charlotte Moser, MD, PhD, SVP of Clinical Development
- John R. MacDonald, PhD, SVP of R&D
- Lance Laing, PhD, Chief Science Officer and Co-Founder
- Richard Buller, MD, PhD, Director
- David F. Dalvey, Director
- Leo Furcht, MD, Director
- Polly Murphy, DVM, PhD, Director
- Richard J. Nigon, Director
Last updated: 2024-12-31
Generation Bio Co.
genetic medicines
Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.
Symbol: GBIO
Recent Price: $1.06
Industry: Biotechnology
CEO: Dr. Cameron Geoffrey McDonough M.D.
Sector: Healthcare
Employees: 174
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 655 7500
Last updated: 2024-12-31
Guardion Health Sciences, Inc.
Lumega-Z, Glauco Cetin, Mapcat SF, CSV-1000, CSV-2000
Guardion Health Sciences, Inc. is a specialty health sciences company in the United States, operating in Medical Foods, Nutraceuticals, and Medical Devices segments. They offer vision-specific medical foods and devices for eye health.
Symbol: GHSI
Recent Price: $3.22
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Mark Goldstone
Sector: Healthcare
Employees: 9
Address: 15150 Avenue of Science, San Diego, CA 92128
Phone: 858 605 9055
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
Lumos Pharma, Inc.
LUM-201
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for rare diseases, with its lead candidate LUM-201 in a Phase 2 trial for pediatric growth hormone deficiency.
Symbol: LUMO
Recent Price: $4.34
Industry: Biotechnology
CEO: Mr. Richard J. Hawkins
Sector: Healthcare
Employees: 33
Address: 4200 Marathon Boulevard, Austin, TX 78756
Phone: 512 215 2630
Last updated: 2024-12-31
Novo Integrated Sciences, Inc.
multidisciplinary primary health care related products and services
Novo Integrated Sciences, Inc., along with its subsidiaries, provides multidisciplinary primary healthcare products and services, operating through healthcare services and product manufacturing segments.
ESG | About | Vision/Values | Leadership | About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: NVOS
Recent Price: $0.05
Industry: Medical - Care Facilities
CEO: Mr. Robert Mattacchione
Sector: Healthcare
Employees: 127
Address: 11120 NE 2nd Street, Bellevue, WA 98004
Phone: 206 617 9797
Leadership
- Robert Mattacchione, CEO, Novo Integrated Sciences
- Chris David, COO, Novo Integrated Sciences
- Robert Oliva, President, Novo Integrated Sciences
- Dr Joseph M. Chalil, Chief Medical Officer (CMO), Chairman, Medical Advisory Board
- Vivek Sethi, NVOS Principal Financial Officer (PFO)
- James Asher, President
- Christopher Wade, NHL EVP, Strategy & Operations
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
SELLAS Life Sciences Group, Inc.
galinpepimut-S (GPS)
SELLAS Life Sciences Group, Inc. is a late-stage biopharmaceutical company focusing on the development of novel cancer immunotherapies in the United States. Their lead product candidate, galinpepimut-S (GPS), is in Phase III clinical trials for acute myeloid leukemia and Phase 1/2 for ovarian cancer.
Symbol: SLS
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. Angelos M. Stergiou M.D., ScD h.c.
Sector: Healthcare
Employees: 16
Address: Times Square Tower, New York, NY 10036
Phone: 646 200 5278
Last updated: 2024-12-31
Vigil Neuroscience, Inc.
VGL101
Vigil Neuroscience, Inc. is a microglia-focused company developing disease-modifying therapeutics for neurodegenerative diseases. Their lead product candidate, VGL101, is a monoclonal antibody in Phase I trial for various neurodegenerative conditions.
Symbol: VIGL
Recent Price: $1.53
Industry: Biotechnology
CEO: Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Sector: Healthcare
Employees: 64
Address: 1 Broadway, Cambridge, MA 02142
Phone: 857 254 4445
Last updated: 2024-12-31
Globus Medical, Inc.
Healthcare Solutions
Globus Medical, Inc. develops and commercializes healthcare solutions for musculoskeletal disorders, offering spine products, motion preservation technologies, and treatment for orthopedic trauma among others.
Symbol: GMED
Recent Price: $82.67
Industry: Medical - Devices
CEO: Mr. Daniel T. Scavilla
Sector: Healthcare
Employees: 5000
Address: 2560 General Armistead Avenue, Audubon, PA 19403
Phone: 610 930 1800
Last updated: 2024-12-31
NeueHealth, Inc.
Neue Care and Neue Solutions
Neue Health, Inc. provides comprehensive healthcare services in the United States through its Neue Care and Neue Solutions segments. The company focuses on delivering healthcare services to various markets including ACA, medicare, and medicaid through risk-bearing clinics, and offers integrated care solutions and performance-based arrangements for providers.
Symbol: NEUE
Recent Price: $7.40
Industry: Medical - Equipment & Services
CEO: Mr. George Lawrence Mikan III
Sector: Healthcare
Employees: 1252
Address: 9250 NW 36th St, Doral, FL 33178
Phone: 612 238 1321
Last updated: 2024-12-31
Cosmos Health Inc.
pharmaceuticals, nutraceuticals, medical devices
Cosmos Health Inc. is a vertically integrated pharmaceutical company offering branded and generic pharmaceuticals, medical devices, and more, serving wholesale distributors and retail pharmacies. Headquartered in Chicago, it has distribution centers in Greece and the UK.
Symbol: COSM
Recent Price: $0.67
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Grigorios Siokas
Sector: Healthcare
Employees: 123
Address: 141 West Jackson Boulevard, Chicago, IL 60604
Phone: 312 536 3102
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
American Vanguard Corporation
AMVAC AGri Center Agrinos AMGUARD Environmental Technologies
American Vanguard Corporation develops, manufactures, and markets specialty chemicals for various uses including agriculture and commercial sectors, with a focus on crop protection, turf, ornamental markets, and public health applications. The company is a leader in precision agriculture and sustainability, offering a diverse range of products globally.
Symbol: AVD
Recent Price: $4.57
Industry: Agricultural Inputs
CEO: Mr. Timothy J. Donnelly Esq.
Sector: Basic Materials
Employees: 845
Address: 4695 MacArthur Court, Newport Beach, CA 92660
Phone: 949 260 1200
Last updated: 2024-12-31